The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

A comprehensive new study supports evidence of the myriad health benefits of GLP-1 medications like Ozempic and Mounjaro — ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including ...

A new study uncovers how widely used weight loss drugs like Ozempic impact various health conditions while posing notable ...

A new study found that GLP-1 medications like Ozempic can lower your risk for 42 conditions, including dementia. Here's what ...

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...

The first study to assess how weight-loss drugs affect the whole of human health has discovered an "eye-opening" impact on ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

A new study published in the Nature Medicine monthly journal highlights the benefits and risks of weight-loss drugs like ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

Can weight loss drugs curb alcohol addictions? This Louisiana doctor is keeping an eye on new findings and emerging research.